Medicine and Dentistry
Autofluorescence
100%
Advanced Glycation End-Product
84%
Testis Cancer
76%
Maturity Onset Diabetes of the Young
57%
Arteriosclerosis Obliterans
51%
Cardiovascular System
49%
Differentiated Thyroid Cancer
45%
Cardiovascular Disease
44%
Cardiovascular Risk
43%
Diabetes Mellitus
40%
Biological Marker
40%
Cisplatin
40%
Malignant Neoplasm
38%
Diabetes
35%
Atherosclerosis
33%
Metabolic Syndrome
32%
Quality of Life
30%
Intima-Media Thickness
29%
Cancer Therapy
25%
Breast Cancer
25%
Autonomic Function
23%
Diabetic Neuropathy
22%
Pulse Wave Velocity
22%
Heart Rate Variability
22%
Abdominal Aortic Aneurysm
17%
Blood Vessel Injury
17%
C Reactive Protein
16%
Blood Pressure
16%
Bilirubin
16%
Hazard Ratio
16%
Bleomycin
16%
Etoposide
16%
Neoplasm
16%
Von Willebrand Factor
16%
Paroxysmal Atrial Fibrillation
15%
Glycoprotein
15%
Ovarian Cancer
15%
Exercise
15%
Non Small Cell Lung Cancer
15%
Glucose Uptake
15%
Salpingooophorectomy
15%
Finger Dermatoglyphics
15%
Atrial Fibrillation
14%
Insulin Resistance
13%
Blood Clotting Factor 8
13%
Carotid Artery Stenosis
13%
Arterial Stiffness
12%
Pressoreceptor Reflex
12%
Symptom
12%
Endothelial Function
12%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
67%
Cardiovascular Disease
52%
Advanced Glycation End Product
51%
Differentiated Thyroid Cancer
47%
Testis Cancer
45%
Biological Marker
39%
Cardiovascular Risk
39%
Malignant Neoplasm
33%
Peripheral Occlusive Artery Disease
31%
Cisplatin
28%
Non Insulin Dependent Diabetes Mellitus
26%
Bilirubin
24%
Atherosclerosis
24%
Diabetes Mellitus
22%
Metabolic Syndrome X
19%
Hypothyroidism
19%
Thyroid Hormone
17%
Breast Cancer
16%
Metformin
15%
Verapamil
15%
Amlodipine
15%
Atrial Fibrillation
13%
C Reactive Protein
13%
Brain Natriuretic Peptide
12%
Inflammation
12%
All Cause Mortality
11%
High Density Lipoprotein Cholesterol
10%
Bleomycin
9%
Etoposide
9%
Heart Disease
9%
Cardiovascular Mortality
9%
Prospective Cohort Study
9%
Thromboembolism
8%
Hyperthyroidism
8%
Subclinical Hyperthyroidism
8%
Placebo
8%
Venous Thromboembolism
8%
Observational Study
8%
Hypercoagulability
7%
Chronic Kidney Failure
7%
End Stage Renal Disease
7%
Linolenic Acid
7%
High Density Lipoprotein
7%
Carboplatin
7%
Thyroid Carcinoma
7%
Very Low Density Lipoprotein
7%
Glycoprotein
7%
Protein Tyrosine Kinase Inhibitor
7%
Glucagon Like Peptide 1 Receptor Agonist
7%
Blood Stasis
7%
Keyphrases
Skin Autofluorescence
58%
Chemotherapy
41%
Peripheral Arterial Disease
38%
Cardiovascular Risk
37%
Testicular Cancer
35%
Advanced Glycation End Products
33%
Testicular Cancer Survivors
31%
Metabolic Syndrome
30%
Cisplatin-based Chemotherapy
28%
Type 2 Diabetes Mellitus (T2DM)
26%
Heart Rate Variability
26%
Cancer Patients
24%
Cancer Treatment
23%
Differentiated Thyroid Carcinoma
22%
Cardiovascular Events
22%
Risk Factors
20%
Confidence Interval
19%
In Cancer
17%
Vascular Complications
16%
Hazard Ratio
15%
Bilirubin
15%
Cardiovascular Disease
14%
GlycA
14%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
11%
Cardiovascular Morbidity
11%
Prospective Cohort Study
11%
Diabetic Patients
10%
VO2peak
10%
Major Adverse Cardiovascular Events
10%
Vascular Damage
10%
Quality of Life
10%
High Risk
9%
Exercise Intervention
9%
Cardiorespiratory Fitness
9%
All-cause Mortality
9%
Type 1 Diabetes Mellitus (T1DM)
9%
Cardiac Disease
8%
Antioxidant System
8%
Optimal Timing
8%
Chronic Kidney Disease
8%
Testosterone
8%
Event-triggered Control
8%
Baroreceptor Reflex Sensitivity
7%
Paclitaxel Chemotherapy
7%
Cancer Survivors
7%
Disease Risk
7%
Thyroid Hormone Suppression
7%
High-density Lipoprotein Cholesterol (HDL-C)
7%
Genetic Loci
7%
Glucose Uptake
7%